Placenta accreta spectrum

From WikiMD's Medical Encyclopedia

Revision as of 00:37, 24 February 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Placenta accreta spectrum (PAS) is a complication of pregnancy characterized by the abnormal adherence of the placenta to the myometrium, the middle layer of the wall of the uterus. It is a significant cause of maternal mortality and morbidity worldwide.

Classification

PAS is classified into three types based on the depth of placental invasion into the uterine wall:

  • Placenta accreta: The placenta attaches too deeply and firmly, but it does not penetrate the uterine muscle.
  • Placenta increta: The placenta attaches even more deeply, invading the muscle.
  • Placenta percreta: The placenta penetrates through the entire uterine wall and can attach to other organs such as the bladder.

Risk factors

The primary risk factor for PAS is placenta previa in the presence of a uterine scar, typically from a previous cesarean section. Other risk factors include advanced maternal age, high parity, and previous uterine surgery or curettage.

Diagnosis

PAS is typically diagnosed through ultrasound during the second or third trimester of pregnancy. Magnetic resonance imaging (MRI) may also be used if ultrasound results are inconclusive.

Treatment

The treatment for PAS is usually planned cesarean delivery followed by hysterectomy. In some cases, conservative management may be considered, where the placenta is left in place and allowed to resorb naturally.

Prognosis

The prognosis for PAS depends on the severity of the condition, the woman's overall health, and the quality of medical care received. With appropriate management, most women with PAS can expect a good outcome.

See also

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.